Invention Application
US20130110188A1 METHOD TO ASSESS HEMODYNAMIC PERFORMANCE DURING CARDIAC RESYNCHRONIZATION THERAPY OPTIMIZATION USING ADMITTANCE WAVEFORMS AND DERIVATIVES 有权
在使用化疗波形和衍生物的心脏再生治疗治疗优化中评估血液动力学性能的方法

  • Patent Title: METHOD TO ASSESS HEMODYNAMIC PERFORMANCE DURING CARDIAC RESYNCHRONIZATION THERAPY OPTIMIZATION USING ADMITTANCE WAVEFORMS AND DERIVATIVES
  • Patent Title (中): 在使用化疗波形和衍生物的心脏再生治疗治疗优化中评估血液动力学性能的方法
  • Application No.: US13663920
    Application Date: 2012-10-30
  • Publication No.: US20130110188A1
    Publication Date: 2013-05-02
  • Inventor: Yong K. ChoDouglas A. HettrickTodd M. Zielinski
  • Applicant: Medtronic , Inc.
  • Applicant Address: US MN Minneapolis
  • Assignee: Medtronic, Inc.
  • Current Assignee: Medtronic, Inc.
  • Current Assignee Address: US MN Minneapolis
  • Main IPC: A61N1/365
  • IPC: A61N1/365
METHOD TO ASSESS HEMODYNAMIC PERFORMANCE DURING CARDIAC RESYNCHRONIZATION THERAPY OPTIMIZATION USING ADMITTANCE WAVEFORMS AND DERIVATIVES
Abstract:
An implantable medical device and associated method to determine an optimal control parameter setting for controlling a cardiac therapy that includes a therapy delivery module to deliver cardiac pacing signals at a plurality of pacing rates, and an admittance measurement module to determine admittance signals associated with each of the plurality of pacing rates. A control unit determines metrics of hemodynamic performance corresponding to each of the plurality of pacing rates in response to the determined admittance signals, identifies pacing rates of the plurality of pacing rates as rejected rates in response to the determined metrics of hemodynamic performance, and determines a pacing rate of the plurality of pacing rates as an optimal rate for delivering the cardiac therapy in response to the identified pacing rates.
Information query
Patent Agency Ranking
0/0